Incidence and Impact of Ventilator Associated Multidrug Resistant Pneumonia in Patients with SARS-COV2.
Seife YohannesZaki AhmedRachel SchellingSwaminathan Perinkulam SathyanarayananAlexandra PrattMathew P SchreiberPublished in: Critical care research and practice (2022)
VAP was a common complication of patients intubated for COVID-19 pneumonia. Most patients received empiric antibiotics upon the hospital and/or ICU admission. There was a 40% incidence of multidrug resistant pneumonia. Patients who developed VAP had almost twice as long hospital and ICU LOS.
Keyphrases
- sars cov
- multidrug resistant
- end stage renal disease
- newly diagnosed
- intensive care unit
- healthcare
- emergency department
- peritoneal dialysis
- coronavirus disease
- prognostic factors
- risk factors
- drug resistant
- acinetobacter baumannii
- mechanical ventilation
- cystic fibrosis
- patient reported outcomes
- klebsiella pneumoniae
- adverse drug
- acute respiratory distress syndrome
- extracorporeal membrane oxygenation
- respiratory failure
- acute care